Lupin's Ankleshwar facility wins gold award from American Society for Quality

03 Jan 2020 Evaluate

Lupin’s Ankleshwar facility has won the gold award at the 9th annual conference on quality management, organised by the American Society for Quality (ASQ) at Ahmedabad on November 22, 2019. The nomination case study submitted for this award summarised the transformation project to improve the yield and quality of company’s Cefadroxil products. This is the fourth consecutive year that Lupin's Ankleshwar facility has won the Gold Award from the American Society for Quality.

This year company's nomination highlighted the key outcomes of its ‘Cefadroxil Yield and Quality Improvement’ project, in the past three years, the company won the award for projects that focused on ethambutol yield improvement (2018), 7AE yield improvement (2017) and 7ACCA yield improvement (2016).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×